EBS vs VOO
Emergent Biosolutions Inc (EBS) versus VOO (VOO) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
VOO (VOO) common stock.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
VOO does not have a complete income-statement cache yet.
EBS currently screens at market cap $416.4M. VOO currently screens at market cap $0.
Not investment advice. Open the EBS and VOO stock pages for the full models.
Not investment advice.